District of Columbia Healthcare & Telehealth Compliance Guide
The District of Columbia does not have a single freestanding Corporate Practice of Medicine statute, but its Professional Corporation Act functions as one of the strictest ownership regimes in the country. DC Code § 29-508 requires that every shareholder, director, and specified officer (board chair, president, vice-president, treasurer, secretary) of a medical professional corporation be an individual licensed to render that professional service — meaning a medical PC must be 100% physician-owned and physician-governed. DC Code § 29-511 further limits share transfers to licensed individuals or the corporation itself, closing off any path to non-physician equity. Regulators and courts also apply a 'control test' (interference with clinical judgment, deriving profit from medical services, commercialization of medicine) consistent with strict CPOM jurisdictions like California and New York. A carefully structured PC-MSO arrangement — a physician-owned clinical PC/PLLC paired with a separately owned management services organization limited to non-clinical functions — remains the standard path for telehealth and medspa operators, but the MSO cannot hold equity in, or exert clinical control over, the licensed entity.
- Corporate Practice of Medicine (CPOM): Strict
- Telehealth prescribing permitted: Yes
- In-person exam required first: No
- Audio-only visits allowed: Yes
- Nurse practitioner authority: Full
- Collaborative practice agreement required: No
- Good Faith Exam required: Yes
Telehealth prescribing in District of Columbia
A provider-patient relationship may be established via telehealth in DC without a prior in-person visit, provided the encounter satisfies DC Board of Medicine standards, including an appropriate patient evaluation sufficient to support a diagnosis (17 DCMR § 4618.3–.4). Prescribing based solely on a static online questionnaire, without an interactive evaluation, does not meet this standard. Real-time audio or audio-video communication is expected when no prior provider-patient relationship exists. Providers must hold a DC medical license to treat DC patients, subject to narrow telehealth exceptions for out-of-jurisdiction licensees under DC Code § 3-1201.05.
Controlled substances in District of Columbia
Federal law (the Ryan Haight Act) generally requires a prior in-person medical evaluation before prescribing controlled substances via telehealth, unless a DEA-recognized exception applies. DEA has repeatedly extended pandemic-era telemedicine flexibilities allowing Schedule II-V prescribing via real-time audio-video telemedicine without a prior in-person exam, and as of this writing those flexibilities remain in effect through December 31, 2026 — subject to DEA registration, review of DC's Prescription Drug Monitoring Program, and a legitimate medical purpose. DC does not appear to layer additional state-specific restrictions on top of these federal rules, but providers should confirm current DEA guidance before relying on telehealth-only controlled-substance prescribing; audio-only (non-video) prescribing of controlled substances is generally limited to buprenorphine/opioid-use-disorder treatment under federal safeguards.
Medical director requirements in District of Columbia
Because DC's professional corporation rules require the clinical entity to be 100% physician-owned, medspas, IV therapy clinics, and similar brick-and-mortar operations offering medical services (injectables, IV infusions, prescription-strength treatments) generally need a DC-licensed physician functioning as medical director — approving clinical protocols, supervising staff, and maintaining oversight of prescribing and controlled-substance handling. This is a practical consequence of DC's ownership statute rather than a standalone 'medical director' requirement.
Nurse practitioner scope and collaborative practice in District of Columbia
The Health Occupations Revision General Amendment Act (B25-0545, enacted 2023–2024) repealed DC's collaboration and protocol requirements for advanced practice registered nurses (former DC Code § 3-1206.03), granting nurse practitioners full, independent practice authority. NPs in DC may evaluate, diagnose, prescribe within their certification and DEA registration, and manage treatment without a mandatory collaborating or supervising physician. DC Code §§ 3-1206.01–.04 and § 3-1206.07a govern APRN and certified nurse practitioner scope of practice.
Key operating notes for District of Columbia
DC's professional corporation ownership rules (DC Code §§ 29-508, 29-511) are among the strictest in the country for equity participation in the clinical entity, so telehealth and medspa operators should have DC health-law counsel review any PC-MSO structure before launch, with particular attention to management-fee methodology and clinical-control provisions. DC participates in the Interstate Medical Licensure Compact and other compacts that can streamline physician licensure. Informed consent and standard-of-care documentation equivalent to an in-person visit are required for all telehealth encounters.
Recent regulatory changes in District of Columbia
The Health Occupations Revision General Amendment Act (B25-0545), enacted 2023–2024, repealed the collaboration/protocol requirements for APRNs, formalizing full independent practice authority for nurse practitioners in the District. Federal DEA telemedicine flexibilities for controlled-substance prescribing have been extended four times since 2023 and currently expire December 31, 2026.
Frequently asked questions
How does DC's Corporate Practice of Medicine rule affect my healthcare business?
The District of Columbia doesn't have a single CPOM statute, but its Professional Corporation Act (DC Code § 29-508) requires 100% physician ownership, and physician directors and officers, for any medical professional corporation — one of the strictest ownership regimes in the country. Non-physician investors cannot hold equity in the clinical entity. You'll need a properly structured PC-MSO arrangement, with the MSO limited to non-clinical services, to operate compliantly. TrueEval can guide you through the entity formation and management services agreements required.
Do I need a medical director for my medspa or IV therapy clinic in DC?
Yes — because DC requires the clinical entity behind a medspa, IV therapy clinic, or similar establishment to be 100% physician-owned, you need a DC-licensed physician serving as medical director to develop protocols, provide clinical oversight, and ensure regulatory compliance. TrueEval places board-certified medical directors licensed in DC who understand both telehealth and in-person practice requirements.
Can nurse practitioners practice independently in the District of Columbia?
Yes. Following the 2023–2024 Health Occupations Revision General Amendment Act, DC grants full practice authority to nurse practitioners, allowing them to evaluate, diagnose, prescribe, and manage treatment without a mandatory collaborating physician. TrueEval helps you navigate DC's specific NP scope-of-practice rules for both telehealth and brick-and-mortar operations.
Can I prescribe medications via telehealth in the District of Columbia?
Yes, telehealth prescribing is permitted in DC. No prior in-person visit is required, provided the encounter includes an appropriate patient evaluation meeting DC Board of Medicine standards — a questionnaire alone isn't sufficient. Real-time audio or audio-video is expected for new patient relationships. TrueEval ensures your prescribing protocols meet DC's requirements.
What compliance requirements apply to cash-pay healthcare businesses in the District of Columbia?
Cash-pay healthcare operations in DC — including telehealth, medspas, IV therapy, and wellness clinics — must still comply with DC's health occupation laws, its strict professional-corporation ownership rules, prescribing regulations, and scope-of-practice requirements. The main difference is you won't deal with insurance billing compliance, but you must still maintain a compliant PC-MSO structure, physician oversight, and clinical documentation. TrueEval specializes in cash-pay compliance frameworks for DC.